A detailed history of United Capital Financial Advisers, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 44,608 shares of LLY stock, worth $36.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
44,608
Previous 40,532 10.06%
Holding current value
$36.7 Million
Previous $36.7 Million 7.7%
% of portfolio
0.2%
Previous 0.32%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $3.15 Million - $3.91 Million
4,076 Added 10.06%
44,608 $39.5 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $60,889 - $76,359
-84 Reduced 0.21%
40,532 $36.7 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $1.11 Million - $1.48 Million
1,873 Added 4.83%
40,616 $31.6 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $6.13 Million - $7.23 Million
11,680 Added 43.16%
38,743 $22.6 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $859,401 - $1.18 Million
-1,977 Reduced 6.81%
27,063 $14.5 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $1.45 Million - $1.94 Million
-4,130 Reduced 12.45%
29,040 $13.6 Million
Q1 2023

Aug 14, 2023

BUY
$310.63 - $364.82 $1.28 Million - $1.51 Million
4,130 Added 14.22%
33,170 $11.4 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $3.31 Million - $3.89 Million
-10,656 Reduced 24.31%
33,170 $11.4 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $1.16 Million - $1.35 Million
-3,602 Reduced 7.59%
43,826 $16 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $1.32 Million - $1.51 Million
-4,460 Reduced 8.6%
47,428 $15.3 Million
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $34,005 - $39,926
-122 Reduced 0.23%
51,888 $16.8 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $2.49 Million - $3.1 Million
-10,631 Reduced 16.97%
52,010 $14.9 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $254,530 - $315,873
1,132 Added 1.84%
62,641 $17.3 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $94,180 - $115,901
-425 Reduced 0.69%
61,509 $14.2 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $2.1 Million - $2.72 Million
11,629 Added 23.12%
61,934 $14.2 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $7,230 - $9,359
-44 Reduced 0.09%
50,305 $9.4 Million
Q4 2020

Feb 17, 2021

BUY
$130.46 - $172.63 $241,611 - $319,710
1,852 Added 3.82%
50,349 $8.5 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $164,205 - $189,932
-1,123 Reduced 2.26%
48,497 $7.18 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $291,938 - $351,345
-2,140 Reduced 4.13%
49,620 $8.15 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $1.4 Million - $1.73 Million
-11,720 Reduced 18.46%
51,760 $7.18 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $1.52 Million - $1.88 Million
14,191 Added 28.79%
63,480 $8.34 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $2.99 Million - $3.26 Million
-28,031 Reduced 36.25%
49,289 $5.51 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $907,480 - $1.06 Million
-8,191 Reduced 9.58%
77,320 $8.57 Million
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $127,116 - $149,624
1,142 Added 1.35%
85,511 $11.1 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $2.4 Million - $2.68 Million
22,625 Added 36.64%
84,369 $9.76 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $38,980 - $48,718
-454 Reduced 0.73%
61,744 $6.63 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $225,964 - $259,336
-2,985 Reduced 4.58%
62,198 $5.31 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $134,987 - $159,344
1,819 Added 2.87%
65,183 $5.04 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $185,839 - $199,334
-2,268 Reduced 3.46%
63,364 $5.35 Million
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $379,107 - $420,771
-4,919 Reduced 6.97%
65,632 $5.61 Million
Q2 2017

Aug 14, 2017

BUY
N/A
70,551
70,551 $5.81 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $782B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.